Directory › Lonza

Lonza — Slough

Slough, United Kingdom · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Lonza
Name(s) in FDA data
Lonza Biologics Plc
FEI number(s)
1000583959 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Slough, United Kingdom
Records matched
4 FDA inspections · 1 inspection with posted 483 citations
Most recent FDA inspection in dataset
13 Oct 2022 — VAI

Capabilities (from the company's website)

  • Biologics drug substance
    …Skip to main content Offerings Mammalian and Expression Technologies Offerings Catalog Cell Line Development Benefit from our flex…
  • Formulation & process development
    …ur project’s priorities in terms of timelines, yield optimization and risk.... Learn more Process Development We provide access mammalian cell culture process development, optimization and validation…

Taken from the company's web page for this site. Source: https://www.lonza.com/about-us/our-locations/slough-uk, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 13 Oct 2022
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000583959, inspection ID 1202907)

  2. 05 Sep 2018
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000583959, inspection ID 1097017)

  3. 24 Jun 2016
    Form 483 observations 4 posted Form 483 citation(s)

    Citation summaries (4)
    • 21 CFR 211.113(a): Procedures for non-sterile drug products
    • 21 CFR 211.192: Investigations of discrepancies, failures
    • 21 CFR 211.42(c)(10)(iv): Environmental Monitoring System
    • 21 CFR 211.42(c)(10)(v): Cleaning System

    Source: FDA Data Dashboard – Citations (FEI 1000583959, inspection ID 978909)

  4. 24 Jun 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000583959, inspection ID 978909)

  5. 24 Sep 2012
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000583959, inspection ID 801062)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.